Cas 263754-50-3,Ethyl(E)-3-(2-(3-(2-benzyloxy-3-methylphenyl)propyl)phenyl)-2-propenoate

263754-50-3

Post Buying Request

Basic information

Product Name: Ethyl(E)-3-(2-(3-(2-benzyloxy-3-methylphenyl)propyl)phenyl)-2-propenoate
Synonyms: Ethyl(E)-3-(2-(3-(2-benzyloxy-3-methylphenyl)propyl)phenyl)-2-propenoate
CAS NO:263754-50-3
Molecular Formula:
Molecular Weight: 414.544
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: Ethyl(E)-3-(2-(3-(2-benzyloxy-3-methylphenyl)propyl)phenyl)-2-propenoate(CAS DataBase Reference)
NIST Chemistry Reference: Ethyl(E)-3-(2-(3-(2-benzyloxy-3-methylphenyl)propyl)phenyl)-2-propenoate(263754-50-3)
EPA Substance Registry System: Ethyl(E)-3-(2-(3-(2-benzyloxy-3-methylphenyl)propyl)phenyl)-2-propenoate(263754-50-3)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 263754-50-3(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

263754-50-3 Suppliers

Recommended suppliers

263754-50-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 263754-50-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,6,3,7,5 and 4 respectively; the second part has 2 digits, 5 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 263754-50:
(8*2)+(7*6)+(6*3)+(5*7)+(4*5)+(3*4)+(2*5)+(1*0)=153
153 % 10 = 3
So 263754-50-3 is a valid CAS Registry Number.

263754-50-3Upstream product

263754-50-3Downstream Products

263754-50-3Relevant academic research and scientific papers

Prostaglandin receptor ligands

-

, (2008/06/13)

Compounds and methods for treating prostaglandin mediated diseases, and certain pharmaceutical compositions thereof are disclosed. The compounds are represented by formula II: Ar1—W—Ar2—X—Q??II The compounds of the invention are structurally different from NSAIDs and opiates, and are antagonists of the pain and inflammatory effects of E-type prostaglandins.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 263754-50-3